| 1 |
30488805 | Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer. | 2019 |
1 |
| 2 |
31484456 | Intracellular Delivery of siRNAs Targeting AKT and ERBB2 Genes Enhances Chemosensitization of Breast Cancer Cells in a Culture and Animal Model. | 2019 Sep 3 |
2 |
| 3 |
23403395 | Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. | 2013 Aug 10 |
1 |
| 4 |
32261200 | HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy. | 2013 Sep 28 |
1 |
| 5 |
21109923 | Feasibility of tailored, selective and effective anticancer chemotherapy by direct injection of docetaxel-loaded immunoliposomes into Her2/neu positive gastric tumor xenografts. | 2011 Jan |
4 |
| 6 |
19409087 | QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model. | 2009 |
1 |
| 7 |
17211467 | Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms. | 2007 Jan 29 |
4 |
| 8 |
17372910 | Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel. | 2007 Jul 15 |
1 |
| 9 |
15504738 | Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling. | 2005 Jan 21 |
2 |